Alyeska Investment Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52M | Sell |
1,429,437
-65,914
| -4% | -$2.4M | 0.18% | 151 |
|
|
2025
Q1 | $54.1M | Buy |
1,495,351
+55,611
| +4% | +$2.01M | 0.22% | 137 |
|
|
2024
Q4 | $60.6M | Buy |
1,439,740
+269,733
| +23% | +$11.3M | 0.23% | 111 |
|
|
2024
Q3 | $65M | Buy |
1,170,007
+1,100,007
| +1,571% | +$61.1M | 0.33% | 104 |
|
|
2024
Q2 | $2.88M | Buy |
+70,000
| New | +$2.88M | 0.02% | 373 |
|